Inventor

TAODA YOSHIYUKI

JP32 patents

⚠️ This page may combine multiple inventors who share the name “TAODA YOSHIYUKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TAODA YOSHIYUKI

SHIONOGI & CO

Substituted 10-hydroxy-9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1h-pyrido[1,2-α]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazine-8-carboxamides

Bicyclic carbamoylpyridone derivative having HIV integrase inhibitory activity

Substituted 10-hydroxy-9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1h-pyrido[1,2-a]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazine-8-carboxamides

N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3] oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide having HIV integrase inhibitory activity

Substituted polycyclic carbamolypyridone derivative

Substituted polycyclic carbamoylpyridone derivative

Substituted pyrido[1&#39;,2&#39;:4,5]pyrazino[1,2-a]pyrimidines as HIV integrase inhibitors

Substituted polycyclic carbamoyl pyridone derivative prodrug

Polycyclic pyridone derivative

Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1′,2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having HIV integrase inhibitory activity

Substituted polycyclic carbamoyl pyridone derivative prodrug

Triazine derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same

Polycyclic carbamoylpyridone derivative

Polycyclic carbamoylpyridone derivative

Hydroxypyrimidinone derivatives having inhibitory activity against HIV integrase

Triazine derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same

Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates

Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates

Prodrugs of (4aS, 13ar)-N-[(2,4-difluorophenyl)methyl]-10-hydroxy-9-11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1H-pyrido[1,2-a]pyrrolo[1′,2′:3:4]imidazo[1,2-d]pyrazine-8-carboxamide and their use in the treatment of HIV infection

JOHNS BRIAN ALVIN

Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness

(3S,11aR)-N-[2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide useful as anti-HIV agent

Substituted 9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydor-1H-pyrido[1,2-a]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazines

YOSHIDA HIROSHI

Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity

Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates

UNIV HOKKAIDO NAT UNIV CORP

Arenavirus growth inhibitor comprising polycyclic carbamoylpyridone derivative

Arenavirus growth inhibitor comprising polycyclic carbamoyl pyridone derivative

PURDUE PHARMA LP

Substituted-quinoxaline-type piperidine compounds and the uses thereof

Substituted-quinoxaline-type piperidine compounds and the uses thereof

TAKAHASHI CHIKA

Substituted polycyclic carbamoyl pyridone derivative prodrug

AKIYAMA TOSHIYUKI

Substituted polycyclic carbamoylpyridone derivative

FUCHINO KOUKI

Substituted-quinoxaline-type piperidine compounds and the uses thereof

KAI HIROYUKI

Pyrolinone derivative and pharmaceutical composition comprising the same

Substituted pyrido[1',2':4,5]pyrazino[1,2-a]pyrimidines as HIV integrase inhibitors